The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2022

Filed:

Feb. 27, 2019
Applicant:

Fenwal, Inc., Lake Zurich, IL (US);

Inventors:

Zahra R. Ali, Chicago, IL (US);

Lan T. Nguyen, Vernon Hills, IL (US);

Katherine N. Radwanski, Highland Park, IL (US);

Angela N. Carlson, Arlington Heights, IL (US);

Tanima J. Abedin, Chicago, IL (US);

Assignee:

Fenwal, Inc., Lake Zurich, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 1/36 (2006.01); A61M 1/30 (2006.01); A61M 1/34 (2006.01);
U.S. Cl.
CPC ...
A61M 1/3683 (2014.02); A61M 1/30 (2013.01); A61M 1/3455 (2013.01); A61M 1/3496 (2013.01); A61M 1/3692 (2014.02); A61M 1/3693 (2013.01); A61M 1/3696 (2014.02); A61M 2202/0021 (2013.01); A61M 2202/0429 (2013.01); A61M 2202/0443 (2013.01); A61M 2205/053 (2013.01); A61M 2205/3306 (2013.01);
Abstract

Systems and methods for performing online extracorporeal photopheresis of mononuclear cells are disclosed. During a mononuclear cell collection cycle, blood is removed from a source and separated into a plasma constituent, a mononuclear cell-containing layer, and red blood cells, followed by the collection of a pre-product including at least a portion of the mononuclear cell-containing layer and at least a portion of the separated red blood cells. The mononuclear cell collection cycle may be repeated, followed by the production of a single mononuclear cell product using the collected pre-product(s). The mononuclear cell product is irradiated using a fixed dose of light, such that the mononuclear cell product is produced so as to have a predetermined volume and a predetermined hematocrit, regardless of the number of pre-products used to produce the mononuclear cell product. Following irradiation, at least a portion of the irradiated mononuclear cell product is returned to the source.


Find Patent Forward Citations

Loading…